1Zeis M,Siegel S,Wagner A,et al.Generation of cytotoxic responses in mice and human individuals against hematological malignancies hematological malignancies using survivin-RNA-transfected dendritic cells[J].Immunology,2003,170(11):5391
2Driscoll L,Linehan R,Clynes M.Survivin: role in normal cells and in pathological conditions[J].Curr Cancer Drug Targets,2003,3:131
3Hoffman WH,Biade S,Zilfou JT,et al.Transcriptional repression of the antiapoptotic survivin gene by wild type P53[J].Biol Chem,2002,277:3247
4Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosisi gene,survivin,expreesed in cancer and lymphoma[J].Nat Med,1997,3:917
5Bosch Z,Marnix L,Michael L,et al.Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity[J].Immunotherapy,2002,25:289
6Nestle FO,Alijagic S,Gillet M,et al.Vaccination of melanoma patiens with peptide or tumor lysate-plused dendritic cells[J].Nat Med,1998,4:328
7Schmitz M,Diestelkoetter P,Weigle B,et al.Generation of survivin-specific CD8+T effector cells by dendritic cells pulsed with protein or selected peptides[J].Cancer Res,2000,60:4845
8Anderson MH,Pedersen L,Jurgen C,et al.indentification of a cytotoxix T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients[J].Cancer Res,2000,61:869
9Martin K,Michael R,Verneris,et al.Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells[J].Immun Lett,2001,76(3):169
10Casti C,Dalerba P,Rivoltini L,et al.The apotosis inhibitor protein survivin induces tumors specific CD8+ and CD4+ T cells in colorectal patients[J].Cancer Res,2003,63:4507
同被引文献30
1Mcnally VA, Patterson AV, Williams KJ, et al. Antiangiogenic,bioreductive and gene therapy approaches to the treatment of hypoxictumours[j]. Curr Pharm Des, 2002,8(15):1319.
2Gondi CS, Lakka SS, Yanamandra N. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis [ J ]. Oncogene, 2003, 22 ( 38 ) :5967.
4Vieweg J, Dannull J. Tumor vaccines:from gene therapy to dendritic cells the emerging frontier [J]. Uro Clin North Am,2003,30(3):633.
5St George JA. Gene therapy progress and prospects adenoviral vectors[J]. Gene Ther,2003,10 : 1135.
6Marchisone C, Pfeffer U, Del GF, et al. progress towards gene therapy for cancer[J]. J Exp Clin Cancer Res,2000,19(3):261.
7Carroll JL,Nielsen LL,Pruett SB,et al. The role of natural killer cells in adenovirus-mediated p53 gene therapy[J]. Mol Cancer Ther,2001,1(1):49.
8Das S, EI-Deiry WS, Somasundaram K. Efficient growth inhibition of HPV16 E6 -expressing cells by an adenovious-expressing p53 homologue p73 beta[J]. Oncogene,2003,22(52):8394.
9Saito Y,Swanson X,Mhashilkar AM. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo[j]. Gene Ther,2003,10(23):1961.
10Gotoh A, Shirakawa T, Wada Y. The growth inhibitory effect of p21 adenovirus on and rogen dependent and-independent human prostate cancer cells[J]. BJU Int,2003,92(3):314.
